Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Behe

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine|November 7, 1999
Yttrium-90 DOTATOC: first clinical resultsA Otte, R Herrmann, A Heppeler, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugateM Behe, J Du, W Becker, et al.
EJNMMI Radiopharmacy and Chemistry|March 23, 2018
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticalsJ Koziorowski, M Behe, C Decristoforo, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 30, 2007
[Molecular imaging of apoptosis in cardiovascular diseases]I Böhm, J T Heverhagen, M Behe, et al.
European Journal of Nuclear Medicine|July 1, 1997
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapyA Otte, E Jermann, M Behe, et al.
EJNMMI Radiopharmacy and Chemistry|March 6, 2018
Guidance on validation and qualification of processes and operations involving radiopharmaceuticalsS Todde, P Kolenc Peitl, P Elsinga, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
[Not Available]Thomas G Wendt, G Gademann, C Pambor, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Nuclear Medicine|November 7, 1999
Yttrium-90 DOTATOC: first clinical resultsA Otte, R Herrmann, A Heppeler, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugateM Behe, J Du, W Becker, et al.
EJNMMI Radiopharmacy and Chemistry|March 23, 2018
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticalsJ Koziorowski, M Behe, C Decristoforo, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 30, 2007
[Molecular imaging of apoptosis in cardiovascular diseases]I Böhm, J T Heverhagen, M Behe, et al.
European Journal of Nuclear Medicine|July 1, 1997
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapyA Otte, E Jermann, M Behe, et al.
EJNMMI Radiopharmacy and Chemistry|March 6, 2018
Guidance on validation and qualification of processes and operations involving radiopharmaceuticalsS Todde, P Kolenc Peitl, P Elsinga, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
[Not Available]Thomas G Wendt, G Gademann, C Pambor, et al.
Pageof 2